Rossari Corrects ESOP Grant to 5000 Options

Rossari Biotech Limited submitted a regulatory filing to correct a previous disclosure regarding the grant of Employee Stock Options (ESOPs).

• The company clarified that the number of options granted under the Rossari Employee Stock Option Plan 2019 was inadvertently mentioned as '4000' in its letter dated July 18, 2026.
• The correct number of options granted is '5000'.
• This correction applies to the main body of the previous letter as well as to Annexure I attached to it.
• All other contents, terms, and conditions of the original ESOP grant disclosure remain unchanged.

Compliance and Submission

• The correction was formally submitted to both BSE Limited and the National Stock Exchange of India Limited on July 20, 2026.
• The request was for the exchanges to take the correction on record and disseminate it to all concerned parties.
• The filing was digitally signed by Parul Gupta, Company Secretary & Head - Legal (Membership No.: A38895).